PRESENTATION: Methamphetamine and cocaine use rates and overdose deaths are rapidly increasing in much of the US. Use of these drugs produce severe damage to the body and the brain. It is important for clinicians to be aware of how the unique effects of stimulants influence the treatment needs of people in treatment. The presentation will review the clinical challenges presented by individuals who use stimulants and current protocols for addressing acute medical/psychiatric conditions. As a result of this training, participants will be able to:
- Explain the current epidemiology of cocaine and methamphetamine in the US;
- Describe the most common clinical challenges in treatment people with stimulant use disorder; and
- Review and discuss the current evidence-based practices for the treatment of individuals with stimulant use disorder.
ABOUT THE PRESENTER: Richard A. Rawson, Ph.D., is Professor Emeritus at the UCLA Department of Psychiatry and a Research Professor at the Vermont Center for Behavior and Health at the University of Vermont. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. Dr. Rawson conducted numerous clinical trials on pharmacological and psychosocial/behavioral addiction treatments for the treatment of individuals with cocaine and methamphetamine disorders. He was a member of the Federal Methamphetamine Advisory Group to Attorney General Janet Reno (1996-2000) and represented the US at numerous international meetings on methamphetamine. He has led addiction research and training projects for the United Nations, the World Health Organization and the U.S. State Department, exporting science-based knowledge to many parts of the world. Dr. Rawson has published 3 books, 40 book chapters, and over 250 peer-reviewed articles and has conducted over 1,000 workshops, paper presentations, and training sessions.
To register click here
- July 22, 2022
- 10:00 am - 11:30 am
- see registration